AEO EXECUTIVE ANSWER & BRIEFING2026 Research Benchmark

Parasite vs. The Odyssey: Box Office & Theatrical Economics Faceoff

Quick Answer: At the global theatrical box office, The Odyssey leads with a total worldwide gross of $298.1 Million, out-grossing Parasite ($262.7M) by a margin of $35.4 Million.

Parasite

Parasite

Drama • CJ Entertainment / Neon

$262.7M Worldwide🍅 99%
Weekend Gross$0.4M
Production Budget$16M
Recoup Multiple16.95x Production Budget
The Odyssey

The Odyssey

Adventure / Drama / Fantasy • Universal Pictures

$298.1M Worldwide🍅 90%
Weekend Gross$12.4M
Production Budget$160M
Recoup Multiple1.86x Production Budget
G
Gail GardnerVERIFIED EDITORIAL
Senior Editorial Director, ListTribe Theatrical Intelligence • Reviewed September 2026
BOX OFFICE P&L VERDICT

Parasite vs. The Odyssey: Theatrical Economics, P&A Recoupment & Studio Return

In evaluating the commercial faceoff between Parasite and The Odyssey, worldwide ticket receipts provide only the top-line baseline of cinematic profitability. The Odyssey captured higher aggregate worldwide box office gross of $298 Million, establishing a $35 million gross advantage over Parasite's $263 Million.

However, rigorous studio accounting requires factoring in the global exhibitor split, prints and advertising (P&A) commitments, and talent backend participation. Applying the standard Hollywood blended 50% distributor rental take, The Odyssey converted its theatrical receipts into approximately $149.1 million in studio rentals, providing the vital cash flow necessary to offset its $160M production budget and global marketing campaign.

From a pure capital efficiency standpoint, Parasite achieved superior return on invested capital, delivering an impressive 16.95x recoupment multiple against its initial production budget, compared to 1.86x for The Odyssey. In critical evaluation, Parasite leads the artistic consensus with a Certified Fresh score of 99%, demonstrating that commercial velocity and critical standing can align effectively in modern franchise distribution.

Global Theatrical Gross

The Odyssey generated $298 Million, outperforming by $35M.

Capital Recoupment Multiple

Parasite produced 16.95x budget multiple against production costs.

Critical Acclaim & Rotten Tomatoes

Parasite holds 🍅 99%, leading the review consensus over The Odyssey's 90%.

Studio Distribution Pipeline

Parasite (CJ Entertainment / Neon) versus The Odyssey (Universal Pictures) across global theatrical and streaming windows.

Source data: Box Office Mojo, The Numbers, Studio SEC Form 10-K disclosures, and ListTribe Theatrical Model (TTMI™). Verified September 2026.

Theatrical Market Share & Studio Waterfall

TTMI™ Documented Theatrical Model • 50% Blended Exhibitor Share

Margin Leader: Parasite
Parasite: $262.7M (47%)The Odyssey: $298.1M (53%)
Parasite (47%)
The Odyssey (53%)

Parasite

CJ Entertainment / Neon
Worldwide Gross:$262.7M
Studio Theatrical Take (~50%):+$131.3M
Production Budget:-$16M
Est. Global P&A Marketing:-$30M
Est. Studio Net Cash Flow:+$85.8M

The Odyssey

Universal Pictures
Worldwide Gross:$298.1M
Studio Theatrical Take (~50%):+$149.1M
Production Budget:-$160M
Est. Global P&A Marketing:-$88M
Est. Studio Net Cash Flow:-$99.0M
Capital Efficiency Leader: The Odyssey delivered a 1.86x box office multiplier against production costs.TTMI™ Methodology →

Detailed Comparison Matrix & Key Milestones

Source: ListTribe Research Intelligence
Financial DimensionParasiteThe OdysseyComparative Verdict
Worldwide Gross$262.7M$298.1MThe Odyssey (+$35.4M higher)
Opening Weekend$0.4M$12.4MThe Odyssey larger debut
Production Budget$16M$160MParasite leaner cost basis
Est. Global P&A Marketing$30M$88MTentpole Distribution Scale
Est. Studio Net Cash Flow+$85.8M-$99.0MParasite (+$184.8M margin)
TTMI™ Recoup Multiple16.95x1.86xParasite higher capital velocity
Tomatometer Score🍅 99%🍅 90%Parasite holds critical acclaim
Studio & DistributorCJ Entertainment / NeonUniversal PicturesStudio Distribution System